Medicines Optimisation

Slides:



Advertisements
Similar presentations
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team January 2015.
Advertisements

The Least Imperfect Device Karen Meade Clinical Nurse Specialist The Hillingdon Hospital.
Drug Utilization Review (DUR)
Respiratory Measurement and Treatment Gail M. Maier, Ph.D., R.N. Associate Director, ED&R The Ohio State University Wexner Medical Center Peak Flow and.
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014.
Optimising medicines for COPD and Asthma – an integrated approach.
Respiratory Prescribing
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
COPD GUIDELINES Sarah Cowdell. WHY GUIDELINES MATTER Predicted to be the third leading cause of death by 2030 Cause of over 30,000 deaths in the UK yearly.
Perform and therapeutic benefit of Using a Nebuliser / Inhaler correctly Devangna Bhatia.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
VALUE AND RESPONSIBLE RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Karen Homan NHS Bedfordshire
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
Medicines management update Catherine Butler Medicines Management Pharmacist.
- Progress in the last 40 years has been amazing but all health services, everywhere, still face 5 major problems one of which is unwarranted variation.
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£
Responsible Respiratory Prescribing
Severe breathlessness
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Berkshire West CCG TIPs 28th January 2015
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Areas to cover Analysis of information Recruitment Review.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
Lynn Helliwell.
Medicines Optimisation Putting Patients at the Centre of their Care Jabeen Egan Lead Pharmacist.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Introduction Method Acknowledgements The impact of respiratory virtual clinics in primary care on responsible respiratory prescribing and inhaled corticosteroid.
Current management of COPD and when to refer?
DISPENSING Back to Basics
Learning objectives Review HIV treatment goals
Respiratory Initiatives: GOLD - ABCD, CAT Scores and myCOPD
New inhalers for COPD and asthma 2015
Optimising the use of Inhalers in COPD
Medicines optimisation in Asthma: stepping up and stepping down
COPD The Why, The How, and The Where
Antibiotics: handle with care!
Jessica Case study.
Emergency Department Asthma Care Pathway (EDACP)
Conclusions Purpose Results Results Discussion Methods Conclusions
Research where it is most needed National Respiratory Strategy
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
Cwm Taf UHB COPD MANAGEMENT AND PRESCRIBING GUIDE
Think Pharmacy Sue Sharpe CEO PSNC.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
National COPD Audit Programme
Monitoring asthma in primary care
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Improving Inhaler Technique
MUR and NMS Respiratory Toolkit.
Medicines Optimisation
Asthma Annual Reviews Hetal Dhruve Presented by Anh Vu
12 months before treatment 12 months after treatment
A pragmatic stepped intervention cluster randomized trial
The Aerosol Drug Management Improvement Team
National COPD Audit Programme
Childhood Asthma : Lessons still to be learnt
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Lynn Orford Community Respiratory Team and HOSAR Lead
Nottinghamshire COPD and Asthma Guidelines
Prescribing Update - Respiratory July 2019
Integration of community pharmacy with PCNs
Asthma Education for Families and HCPs
TITLE Respiratory Training Session Deepa Tailor
Optimisation of Respiratory MURs and NMS in Community Pharmacy
Presentation transcript:

Medicines Optimisation SE London asthma and COPD guidelines Finlay Royle Senior Clinical Commissioning Pharmacist Lambeth CCG

Medicines Optimisation Key theme: Quality, Safety and Medicines Waste

Medicines are the most common therapeutic intervention in healthcare, but their use is often suboptimal for a variety of reasons and this can lead to medicines not being used as intended and ‘waste’ in the health economy.

Asthma pyramid outcomes for Lambeth CCG September 2015 against May 2016 The following metrics would be expected to decrease over time: Proportion of patients issued more than 6 prescriptions of short-acting Beta-agonist inhalers Proportion of patients at Step 4 (treatment with high-dose inhaled steroid) The following metrics would be expected to increase over time: Quit Smoking Treatment (in smokers) Carbon monoxide check Asthma action plan issued Inhaled steroid adherence check Spacer issued Very brief advice (smoking cessation) Inhaler technique check These metrics were developed by a panel of asthma and respiratory experts alongside generalists in Lambeth, Southwark and KHP, to test whether they could measure ‘good quality asthma care’, based upon National Review of asthma deaths and BTS/SIGN guidelines on asthma. The metrics were used to assist individual practices assess their performance against these measures and to address specific issues within the practice. Data will continue to be analysed to determine if further change occurs. Over time, these data should be aligned to asthma admission and outcomes data to see if there is correlation. The biggest changes in Lambeth practices were seen in: issuing of Personalised Asthma Action Plans issuing of spacer devices for those using pressurised Meter Dose Inhalers checking of inhaler technique Areas for improvement identified amongst Lambeth practices: 1. Quit smoking treatment and CO check 2. Inhaler technique checks

Introduce the scheme

SEL Respiratory Guidelines: Management of COPD & Asthma New inhaler treatments available on market: New molecules New combinations New devices Previous guidelines across L&S out of date SE London group set up: Consultants, nurses, pharmacists across SEL Review evidence, safety and value Patient feedback on devices Guidelines for asthma & COPD

SEL Respiratory Guidelines: Management of COPD & Asthma General recommendations: Detect & treat tobacco addiction Branded prescribing Patient adherence / technique check Self-management plans High-dose inhaled steroid – specialist Spacer device for Metered-dose inhalers

Asthma

Asthma – key changes In general practice: Spiromax device for budesonide/formoterol Fostair – Nexthaler / DPI MART therapy Specialist recommendations / step 4: High-strength steroids: Relvar Ellipta, or Flutiform NOT Seretide Fostair (high-strength) Tiotropium (softmist inhaler)

Respiratory – asthma New devices on formulary: DuoResp Spiromax Fostair Nexthaler (& MDI) Easyhalers Lower lid to present dose Open lid to present dose Click to present dose Budesonide + formoterol Beclometasone + formoterol Various drugs Dose counter If cap is opened, dose released, counter decreases Counter only decreases if powder inhaled If clicked, dose released, counter decreases Nexthaler – powder stays in reservoir until inhaled. Ie if opened and then closed, but not inhaled, counter does not decrease and dose remains available in the reservoir. DuoResp Spiromax – dose counter decreases and dose is released every time lid is opened Easyhalers – beclometasone, budesonide, salbutamol and formoterol (separates). Double-clicking before inhaling results in double dosing. Simple click to release the dose. Dose counter

COPD

COPD – key changes In general practice: New LAMA/LABA devices – place in therapy Medicines Optimisation Scheme PR, tobacco addiction and vaccinations Specialist recommendations / step 4: Refer to specialist for triple therapy and/or when patient exacerbates Options for triple therapy

Lower cap to present dose Respiratory – COPD LABA / LAMA devices on formulary: Ultibro Breezhaler Duaklir Genuair Anoro Ellipta Insert capsule, pierce Click to present dose Lower cap to present dose Once daily dosing Twice-daily dosing Visual indicator Audible and visual indicators Ellipta device available for steroid Rx Follow-on from Seebri Breezhaler Follow-on from Eklira Genuair Follow-on from Incruse Ellipta

https://antibioticguardian.com/ Make a pledge to be an Antibiotic Guardian It takes less than 2 minutes https://antibioticguardian.com/ The campaign urges members of the public and healthcare professionals to take action in helping to slow antimicrobial resistance by making a pledge about how they can personally help conserve these vital medicines, ensuring they work now and in the future.